The Infectious Diseases Society of America (IDSA) recommends ophthalmic examinations for all culture positive candidemia patients, acknowledging the risk of candida endophthalmitis. However, recent trends have shown a decline in ocular candida involvement, with rates as low as 1%. The Royal College of Ophthalmologists (RCOphth) therefore suggests a more selective, risk-based approach to referrals, considering factors such as whether the patient reports ocular symptoms, overall prognosis, microbiology results, and ocular penetrance of the chosen antifungal agent. As a result of a discrepancy in guidelines, the decision often falls to ward doctors whether or not to make a referral, who may lack specific expertise in this area.